rs193024188
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_004260.4(RECQL4):c.2260C>T(p.Arg754Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00044 in 1,609,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000182 AC: 44AN: 241158Hom.: 0 AF XY: 0.000143 AC XY: 19AN XY: 132462
GnomAD4 exome AF: 0.000458 AC: 667AN: 1456932Hom.: 0 Cov.: 47 AF XY: 0.000450 AC XY: 326AN XY: 724968
GnomAD4 genome AF: 0.000269 AC: 41AN: 152380Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74514
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 29641532) -
RECQL4: BP4 -
- -
- -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.2260C>T (p.Arg754Trp) missense change has a maximum subpopulation frequency of 0.05% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools are not in agreement about the effect of this variant on protein function, but to our knowledge these predictions have not been confirmed by functional assays. This variant has been identified in 2 of 1358 control individuals collected as part of a non-cancer studies (PMID: 29641532). To our knowledge, this variant has not been reported in individuals with RECQL4-associated conditions. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Baller-Gerold syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at